Lttl Review

Lttl: the whole price grid is public, and the cheap number is the annual one

Lttl (say “little”) sells compounded semaglutide and tirzepatide injections, a low-dose “microdose” line that includes a needle-free dissolving semaglutide tablet, and a menu of longevity peptides. The reason to look at it is the plans page. Every product is laid against every commitment length, with the savings next to each row, before you answer a single question. The homepage's “Plans start at” figures are the 12-month prepay tier, not what you'd pay month to month.

How the pricing actually works — and the catch

Each injectable has four tiers: Monthly Auto-Refill, a 3-month supply billed quarterly, a 6-month supply, and a 12-month supply billed annually up front. Tirzepatide on the monthly plan is $149 a month; semaglutide's monthly rate is about a third less. Moving to the annual tier saves roughly ten dollars a month on either drug. The crossed-out list prices are more than double the current ones. Against a category median of about $179, both injectables land well under the middle of the market.

How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 508 GLP-1 providers we track.

The monthly row is labeled a “4-Week Supply,” so a year of auto-refills is thirteen charges, not twelve. The price is flat as you titrate. Lttl's wording, repeated on every product page, is “Same price at every dose.” A site-wide banner promises a first-month discount with a code “auto-applied,” but the plans grid shows no first-month row for the injectables. The only intro prices are on the microdose line, where a one-time “First Month Special” is $119 for the injections and $149 for the tablet. Lttl doesn't bill insurance; it points you to HSA and FSA funds instead.

The refund terms are the strictest part of the deal. A full refund is offered only if a provider finds you medically ineligible at the initial consultation, or for a billing error, and requests must be emailed within 28 days. The terms also say that “Once the initial medical intake has been submitted, the order is considered processed and is non-refundable.” Canceling stops future charges but returns nothing already paid, and shipped medication can't come back. One inconsistency worth knowing: the pricing page says you're charged only once a provider issues a plan, while the refunds page calls consultation fees “generally non-refundable” regardless of whether a prescription is issued.

Medications, formats and the dose ladder

The weight-loss menu is two weekly injections: compounded semaglutide and compounded tirzepatide. The microdose line offers the same two molecules at lower strengths, which Lttl describes as “combined with supportive nutrients” without naming them. Microdose semaglutide or tirzepatide runs $149 a month on the standing monthly plan, $119 a month on the six-month prepay, and less on the annual. The microdose tab also lists a needle-free semaglutide tablet that dissolves in the mouth (an ODT), at $179 a month on the monthly plan, $149 for the first month, and lower on prepay. Lttl doesn't sell brand-name Wegovy, Zepbound, Ozempic or Mounjaro.

Lttl doesn't publish its own compounded dose ladder in mg. Its product pages describe the standard labeled schedules instead: semaglutide “generally begins at 0.25 mg once weekly for four weeks” and climbs toward the 2.4 mg maintenance dose, and tirzepatide “generally begins at 2.5 mg once weekly for four weeks.” The microdose strengths, injection or tablet, aren't stated in mg at all.

• Semaglutide injectable — the cheaper of the two, with the annual tier the lowest number on the site
• Tirzepatide injectable — $149 a month on Monthly Auto-Refill, a 4-week supply that renews until you cancel
• Microdose semaglutide or tirzepatide — $119 first-month special, then $149 a month unless you prepay
• Microdose semaglutide tablet (ODT) — $149 first-month special, then $179 a month unless you prepay
• Longevity line — sermorelin, NAD+, MIC+B12, L-carnitine, glutathione and methylene blue, which this review doesn't score

What the intake asks — and where it stops you

Every “Get Started” button leads to what Lttl calls a “Free 2-Minute Assessment.” The very first screen asks for your legal first and last name, your state and your zip code, before a single health question. So the assessment is free, but it isn't anonymous. The pricing page describes the review as “An asynchronous medical assessment reviewed by a U.S.-licensed provider,” and nowhere on the site is a video visit mentioned, so expect a written intake and messaging rather than a call.

Timing is where the marketing and the policy disagree. A banner on every page reads “Prescribed and shipped within 48 hours,” and the semaglutide page says “Arrives in 1-2 days.” The shipping policy says most orders are processed by the pharmacy within 2–5 business days after a prescription, then arrive 3–7 business days after leaving the pharmacy. Plan on the policy, not the banner. Medication ships cold-chain with tracking, a signature may be required, and delivery repeats monthly on the auto-refill plan. Support is a weekday phone line, email with a one-business-day reply, and a patient portal.

Trust and safety: what Lttl publishes and what it doesn't

Lttl is unusually blunt about the medication. Its FAQ states the compounded GLP-1s “are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.” Its about page says “Lttl is LegitScript Certified,” and the seal links to LegitScript's lookup tool. There are no FDA warning letters against Lttl or its operator, The Commerce Group Holdings, LLC.

Two gaps matter for a purchase like this. Lttl doesn't publish a list of states served; the FAQ says only “in U.S. states where our partner providers are licensed,” and you find out during the assessment. And it never names a pharmacy. The terms refer to “Partner Pharmacies” and tell patients not to contact them directly. Prescribing is left to “independent networks of U.S.-licensed clinicians,” and the advisory board it does name is a clinical pharmacist, a family nurse practitioner and a physical therapist. The marketing claims (“Join 500,000+ others,” “Average Lttl members lose 32 lbs in their first 6 months,” a “Forbes Health's Best Provider of 2026” banner) come with no source you can check, and its Trustpilot profile is tiny: 4.4 out of 5 from 11 reviews. The terms also require individual arbitration and waive class actions.

Who should choose it — and who should skip it

Choose Lttl if price is the deciding factor and you'll read the grid before you buy. Both injectables sit well under the category median, and the flat-at-every-dose promise is written on every product page. The low-dose microdose line, which Lttl pitches at people who found a full dose hard to tolerate, is priced as its own product, with a needle-free tablet if you'd rather not inject.

Skip it if you want to know which pharmacy is compounding your vial or which states are covered before you hand over your name. Skip it if a refund after intake matters, because there isn't one. Skip it if you want brand-name medication.

Bottom line

Lttl's pricing page shows you the whole grid up front, and its month-to-month rates are low even before you prepay. The trade is disclosure: an unnamed pharmacy, an unpublished state list, an intake that starts with your legal name, and refund terms that close the moment you submit it. If you can live with that, it's a strong budget pick for a flat-priced compounded GLP-1 with a low-dose option. Confirm your state during the assessment, and treat the 48-hour banner as marketing. See how these factors are weighed in our scoring methodology.

If you're weighing alternatives, altRX ($89/month) and bmiMD ($99/month) are among the closest options we track to Lttl.